Literature DB >> 23635949

Epithelial-mesenchymal transition-related microRNA-200s regulate molecular targets and pathways in renal cell carcinoma.

Hirofumi Yoshino1, Hideki Enokida, Toshihiko Itesako, Shuichi Tatarano, Takashi Kinoshita, Miki Fuse, Satoko Kojima, Masayuki Nakagawa, Naohiko Seki.   

Abstract

Our recent studies of microRNA (miRNA) expression signatures demonstrated that the epithelial-mesenchymal transition (EMT)-related microRNA-200 family (miR-200s: miR-200a/b/c, miR-141 and miR-429) were significantly downregulated in renal cell carcinoma (RCC) and putative tumor-suppressive miRNAs in RCC. In this study, our aim was to investigate the functional significance of the miR-200s in cancer cells and to identify novel miR-200s-regulated molecular targets and pathways in RCC. Expression levels of all the miR-200s members were significantly downregulated in human RCC tissues compared with normal renal tissues. Restoration of mature miR-200s in RCC cell line resulted in significant inhibition of cell proliferation and migration, suggesting that miR-200s function as tumor suppressors in RCC. Furthermore, we utilized gene expression analysis and in silico database analysis to identify miR-200s-regulated molecular targets and pathways in RCC. The miR-200s was categorized into two groups, according to their seed sequences, miR-200b/c/429 and miR-200a/141. Our data demonstrated that the 'Focal adhesion' and 'ErbB signaling' pathways were significantly regulated by miR-200b/c/429 and miR-200a/141, respectively. The identification of novel tumor-suppressive miR-200s-regulated molecular targets and pathways has provided new insights into RCC oncogenesis and metastasis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23635949     DOI: 10.1038/jhg.2013.31

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  46 in total

Review 1.  Aberrantly expressed microRNAs in bladder cancer and renal cell carcinoma.

Authors:  Akira Kurozumi; Yusuke Goto; Atsushi Okato; Tomohiko Ichikawa; Naohiko Seki
Journal:  J Hum Genet       Date:  2016-06-30       Impact factor: 3.172

2.  miR-200b and cancer/testis antigen CAGE form a feedback loop to regulate the invasion and tumorigenic and angiogenic responses of a cancer cell line to microtubule-targeting drugs.

Authors:  Youngmi Kim; Deokbum Park; Hyuna Kim; Munseon Choi; Hansoo Lee; Yun Sil Lee; Jongseon Choe; Young Myeong Kim; Dooil Jeoung
Journal:  J Biol Chem       Date:  2013-10-30       Impact factor: 5.157

3.  Tumor suppressive microRNA-200a inhibits renal cell carcinoma development by directly targeting TGFB2.

Authors:  Ruijing Lu; Ziliang Ji; Xiaoqing Li; Jie Qin; Guanghui Cui; Jing Chen; Qingna Zhai; Chunjuan Zhao; Wei Zhang; Zhendong Yu
Journal:  Tumour Biol       Date:  2015-03-27

4.  MicroRNA-200b suppresses arsenic-transformed cell migration by targeting protein kinase Cα and Wnt5b-protein kinase Cα positive feedback loop and inhibiting Rac1 activation.

Authors:  Zhishan Wang; Brock Humphries; Hua Xiao; Yiguo Jiang; Chengfeng Yang
Journal:  J Biol Chem       Date:  2014-05-19       Impact factor: 5.157

5.  Transcription Factor Hepatocyte Nuclear Factor-1β (HNF-1β) Regulates MicroRNA-200 Expression through a Long Noncoding RNA.

Authors:  Sachin S Hajarnis; Vishal Patel; Karam Aboudehen; Massimo Attanasio; Patricia Cobo-Stark; Marco Pontoglio; Peter Igarashi
Journal:  J Biol Chem       Date:  2015-08-19       Impact factor: 5.157

6.  MiR-200c-3p inhibits cell migration and invasion of clear cell renal cell carcinoma via regulating SLC6A1.

Authors:  Naibijiang Maolakuerban; Baihetiya Azhati; Hamulati Tusong; Asimujiang Abula; Anniwaer Yasheng; Ayiding Xireyazidan
Journal:  Cancer Biol Ther       Date:  2018-02-02       Impact factor: 4.742

7.  MicroRNA-495 suppresses human renal cell carcinoma malignancy by targeting SATB1.

Authors:  Cai Lv; Zhiming Bai; Zhenxiang Liu; Pengcheng Luo; Jie Zhang
Journal:  Am J Transl Res       Date:  2015-10-15       Impact factor: 4.060

8.  Zeb1 affects epithelial cell adhesion by diverting glycosphingolipid metabolism.

Authors:  Daniel Mathow; Federica Chessa; Mariona Rabionet; Sylvia Kaden; Richard Jennemann; Roger Sandhoff; Hermann-Josef Gröne; Alexander Feuerborn
Journal:  EMBO Rep       Date:  2015-02-02       Impact factor: 8.807

9.  MiR-429 is linked to metastasis and poor prognosis in renal cell carcinoma by affecting epithelial-mesenchymal transition.

Authors:  Tana Machackova; Hana Mlcochova; Michal Stanik; Jan Dolezel; Michal Fedorko; Dalibor Pacik; Alexandr Poprach; Marek Svoboda; Ondrej Slaby
Journal:  Tumour Biol       Date:  2016-09-12

Review 10.  Epithelial to Mesenchymal Transition in Renal Cell Carcinoma: Implications for Cancer Therapy.

Authors:  Francesco Piva; Matteo Giulietti; Matteo Santoni; Giulia Occhipinti; Marina Scarpelli; Antonio Lopez-Beltran; Liang Cheng; Giovanni Principato; Rodolfo Montironi
Journal:  Mol Diagn Ther       Date:  2016-04       Impact factor: 4.074

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.